Your session is about to expire
← Back to Search
Ketorolac Tromethamine for Breast Reconstruction
Study Summary
This trial will study whether giving ketorolac before breast surgery can reduce post-operative pain and the amount of opioids needed afterwards.
- Breast Reduction
- Breast Reconstruction
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Do I fulfill the requirements for participation in this research endeavor?
"This research is looking for 183 women aged 18-64 who are seeking breast reduction or reconstruction. The key eligibility criteria include an adult female patient consenting to the clinical trial."
What potential hazards exist when ingesting Ketorolac Tromethamine?
"Because the trial is in its opening stages, with limited data on safety and efficacy available, Ketorolac Tromethamine received a score of 1."
What is the current tally of participants in this experiment?
"Affirmative. Clinicaltrials.gov provides evidence that this clinical experiment is actively enrolling individuals, with first postings beginning on June 22nd 2020 and most recent revisions occuring May 4th 2021. This research study seeks 183 participants from one location."
Are participants beyond the age of sixty being considered for this experiment?
"This research initiative is currently seeking adult participants with ages ranging from 18 to 64."
Are there still available slots to join this research endeavor?
"True. According to the information hosted on clinicaltrials.gov, patient recruitment has begun for this trial that was initially posted on June 22nd 2020 and last updated May 4th 2021. A total of 183 patients are needed at a single site."
Is there a history of research surrounding Ketorolac Tromethamine?
"Presently, 38 medical trials are being conducted to research Ketorolac Tromethamine. 8 of these ongoing investigations are in Phase 3 and 57 locations across the globe have sites running experiments for this medication. Los Angeles is particularly active with regards to studies about its efficacy."
In what circumstances is Ketorolac Tromethamine typically prescribed?
"Ketorolac Tromethamine is often used to alleviate ocular itching. It has also been shown to provide temporary relief for pain, facilitate the induction of a nerve block and regulate pupil size."
Share this study with friends
Copy Link
Messenger